134 related articles for article (PubMed ID: 31841475)
1. RADIOTHERMOMETRIC PERSONALISATION OF CHEMO- AND RADIOTHERAPY FOR PATIENTS WITH ADVANCED (III, IVA AND IVB) STAGES MALIGNANT LESIONS OF ORAL CAVITY, THROAT AND EPIGLOTTIS.
Bazyka D; Vorobyov M; Kechyn I; Vorobyov O; Shmykova O
Probl Radiac Med Radiobiol; 2019 Dec; 24():296-311. PubMed ID: 31841475
[TBL] [Abstract][Full Text] [Related]
2. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
Doweck I; Robbins KT; Samant S; Vieira F
World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases.
Kuhnt T; Klockenbrink U; Knipping S; Lautermann J; Kriese K; Wienke A; Hildebrandt G; Hauptmann S
Strahlenther Onkol; 2011 May; 187(5):292-9. PubMed ID: 21533760
[TBL] [Abstract][Full Text] [Related]
5. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx.
Giralt JL; Gonzalez J; del Campo JM; Maldonado J; Sanz X; Pamias J; Eraso A; Bescos S; Raspall G
Cancer; 2000 Sep; 89(5):939-45. PubMed ID: 10964322
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting swallow outcome following treatment for advanced oral and oropharyngeal malignancies.
Kalavrezos N; Cotrufo S; Govender R; Rogers P; Pirgousis P; Balasundram S; Lalabekyan B; Liew C
Head Neck; 2014 Jan; 36(1):47-54. PubMed ID: 23559533
[TBL] [Abstract][Full Text] [Related]
7. [Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome].
Eckardt A; Rades D; Rudat V; Hofele C; Dammer R; Dietl B; Wildfang I; Karstens JH
Mund Kiefer Gesichtschir; 2002 Mar; 6(2):117-21. PubMed ID: 12017874
[TBL] [Abstract][Full Text] [Related]
8. [The role of a surgical method in combined and complex treatment of patients with squamous cell oral and oropharyngeal cancer].
Vikhlianov IV; Shoĭket IaN; Lazarev AF
Khirurgiia (Mosk); 2007; (1):55-8. PubMed ID: 17426691
[TBL] [Abstract][Full Text] [Related]
9. Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
Kovács AF; Schiemann M; Turowski B
J Craniomaxillofac Surg; 2002 Apr; 30(2):112-20. PubMed ID: 12069515
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.
Budach V; Stromberger C; Poettgen C; Baumann M; Budach W; Grabenbauer G; Marnitz S; Olze H; Wernecke KD; Ghadjar P
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):916-24. PubMed ID: 25670541
[TBL] [Abstract][Full Text] [Related]
11. Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.
Hayashi Y; Nakamura T; Mitsudo K; Yamaguchi H; Ono T; Azami Y; Takayama K; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Fuwa N; Tohnai I
Head Neck; 2016 Aug; 38(8):1145-51. PubMed ID: 27018982
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts].
Eckardt A; Wegener G; Karstens JH
Mund Kiefer Gesichtschir; 2006 Jan; 10(1):30-6. PubMed ID: 16365743
[TBL] [Abstract][Full Text] [Related]
13. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
Klug C; Wutzl A; Kermer C; Ploder O; Sulzbacher I; Selzer E; Voracek M; Oeckher M; Ewers R; Millesi W
Int J Oral Maxillofac Surg; 2005 May; 34(3):262-7. PubMed ID: 15741034
[TBL] [Abstract][Full Text] [Related]
14. [Concurrent radiochemotherapy in the treatment of squamous cell oral and oropharyngeal cancer].
Semin DIu; Medvedev VS; Marbynskiĭ IuS; Gulidov IA; Isaev PA; Radzhanova MU; Derbugov DN; Pol'kin VV
Vopr Onkol; 2010; 56(5):544-7. PubMed ID: 21137232
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.
Inhestern J; Oertel K; Stemmann V; Schmalenberg H; Dietz A; Rotter N; Veit J; Görner M; Sudhoff H; Junghanß C; Wittekindt C; Pachmann K; Guntinas-Lichius O
PLoS One; 2015; 10(7):e0132901. PubMed ID: 26186556
[TBL] [Abstract][Full Text] [Related]
16. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.
Mitsudo K; Koizumi T; Iida M; Iwai T; Nakashima H; Oguri S; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
Radiother Oncol; 2014 May; 111(2):306-10. PubMed ID: 24746571
[TBL] [Abstract][Full Text] [Related]
17. Optimization of preoperative chemotherapy by ultrasound. Follow-up in tumours of the oral cavity and oropharyngeal region.
Mende U; Zöller J; Drommer RB; Reichardt P; Born IA
Int J Oral Maxillofac Surg; 1990 Dec; 19(6):363-6. PubMed ID: 2128315
[TBL] [Abstract][Full Text] [Related]
18. Functional and oncological results of non-surgical vs surgical treatment in squamous cell carcinomas of the oropharynx.
Díaz-Molina JP; Rodrigo JP; Alvarez-Marcos C; Blay P; de la Rúa A; Estrada E; Alonso R
Acta Otorrinolaringol Esp; 2012; 63(5):348-54. PubMed ID: 22503508
[TBL] [Abstract][Full Text] [Related]
19. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
Hong RL; Hsiao CF; Ting LL; Ko JY; Wang CW; Chang JTC; Lou PJ; Wang HM; Tsai MH; Lai SC; Liu TW
Ann Oncol; 2018 Sep; 29(9):1972-1979. PubMed ID: 30016391
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.
Tangthongkum M; Kirtsreesakul V; Supanimitjaroenporn P; Leelasawatsuk P
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2567-2572. PubMed ID: 28321535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
